Alembic Pharmaceuticals Shareholding Pattern
- Market cap
- ₹16,391 crore
- P/E
- 23.6
- P/B
- 2.89
- ROE
- 12.4%
- Dividend yield
- 1.44%
As of 30-JUN-2026, promoters held 69.87% of Alembic Pharmaceuticals (+0.13 pp from 31-MAR-2026), foreign institutional investors 4.18%, domestic institutions 15.94% and the public 10.01%.
Source: Shareholding patterns filed with the stock exchanges (company filings). Data as of 7 October 2026. How this data is compiled.
Alembic Pharmaceuticals shareholding pattern — frequently asked questions
What is the promoter holding in Alembic Pharmaceuticals?
Promoters held 69.87% of Alembic Pharmaceuticals as of 30-JUN-2026, up 0.13 pp from 69.74% in 31-MAR-2026.
How much do FIIs hold in Alembic Pharmaceuticals?
Foreign institutional investors held 4.18% of Alembic Pharmaceuticals as of 30-JUN-2026, a change of -0.07 pp from the previous quarter.
How much do domestic institutions hold in Alembic Pharmaceuticals?
Domestic institutional investors, including mutual funds and insurers, held 15.94% of Alembic Pharmaceuticals as of 30-JUN-2026 (-0.24 pp from the previous quarter).
Who owns Alembic Pharmaceuticals?
As of 30-JUN-2026, Alembic Pharmaceuticals' shareholders were promoters (69.87%), foreign institutional investors 4.18%, domestic institutions 15.94% and the public 10.01%, as filed with the stock exchanges.
Same Data For Peers
Trade Alembic Pharmaceuticals With ATS
Track APLLTD live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.